

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 7.62787842 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 7.62787842 |
| 3 | fatty acid elongation (GO:0030497) | 7.31317912 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 6.17353435 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 6.17353435 |
| 6 | nuclear pore complex assembly (GO:0051292) | 5.67554805 |
| 7 | nuclear pore organization (GO:0006999) | 5.09082370 |
| 8 | ensheathment of neurons (GO:0007272) | 4.90527782 |
| 9 | axon ensheathment (GO:0008366) | 4.90527782 |
| 10 | hemidesmosome assembly (GO:0031581) | 4.90428218 |
| 11 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.88790848 |
| 12 | myelination (GO:0042552) | 4.82741604 |
| 13 | response to lipoprotein particle (GO:0055094) | 4.76465961 |
| 14 | ribosome assembly (GO:0042255) | 4.68374474 |
| 15 | COPII vesicle coating (GO:0048208) | 4.65753993 |
| 16 | cholesterol biosynthetic process (GO:0006695) | 4.57050617 |
| 17 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.50475137 |
| 18 | pore complex assembly (GO:0046931) | 4.32390676 |
| 19 | cell adhesion mediated by integrin (GO:0033627) | 4.25704973 |
| 20 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.22102868 |
| 21 | amyloid precursor protein catabolic process (GO:0042987) | 4.12052851 |
| 22 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.11281446 |
| 23 | amyloid precursor protein metabolic process (GO:0042982) | 4.06993570 |
| 24 | sterol biosynthetic process (GO:0016126) | 4.02545484 |
| 25 | protein localization to endosome (GO:0036010) | 3.93017003 |
| 26 | adhesion of symbiont to host cell (GO:0044650) | 3.85301949 |
| 27 | virion attachment to host cell (GO:0019062) | 3.85301949 |
| 28 | myelin maintenance (GO:0043217) | 3.79996231 |
| 29 | thioester biosynthetic process (GO:0035384) | 3.77879528 |
| 30 | acyl-CoA biosynthetic process (GO:0071616) | 3.77879528 |
| 31 | establishment of integrated proviral latency (GO:0075713) | 3.77361841 |
| 32 | very long-chain fatty acid metabolic process (GO:0000038) | 3.75892131 |
| 33 | nucleotide transmembrane transport (GO:1901679) | 3.75023323 |
| 34 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.66855636 |
| 35 | regulation of lipoprotein metabolic process (GO:0050746) | 3.66555859 |
| 36 | L-phenylalanine catabolic process (GO:0006559) | 3.63757986 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.63757986 |
| 38 | creatine metabolic process (GO:0006600) | 3.58558674 |
| 39 | vesicle coating (GO:0006901) | 3.51928570 |
| 40 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.51281283 |
| 41 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.50527211 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.44958113 |
| 43 | L-phenylalanine metabolic process (GO:0006558) | 3.44958113 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.44618456 |
| 45 | regulation of sister chromatid cohesion (GO:0007063) | 3.32547710 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.31899880 |
| 47 | metaphase plate congression (GO:0051310) | 3.29704488 |
| 48 | non-recombinational repair (GO:0000726) | 3.29105684 |
| 49 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.29105684 |
| 50 | regulation of centriole replication (GO:0046599) | 3.29063621 |
| 51 | mitotic metaphase plate congression (GO:0007080) | 3.25645754 |
| 52 | skin morphogenesis (GO:0043589) | 3.23839506 |
| 53 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.23442789 |
| 54 | L-serine transport (GO:0015825) | 3.19377113 |
| 55 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.15052348 |
| 56 | establishment of chromosome localization (GO:0051303) | 3.14749472 |
| 57 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.13724345 |
| 58 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.13344938 |
| 59 | adhesion of symbiont to host (GO:0044406) | 3.12242527 |
| 60 | NADPH regeneration (GO:0006740) | 3.09879153 |
| 61 | pentose-phosphate shunt (GO:0006098) | 3.07831828 |
| 62 | tRNA aminoacylation for protein translation (GO:0006418) | 3.05556993 |
| 63 | import into cell (GO:0098657) | 3.03969910 |
| 64 | magnesium ion transport (GO:0015693) | 2.94722642 |
| 65 | mitotic nuclear envelope disassembly (GO:0007077) | 2.93827650 |
| 66 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.93546972 |
| 67 | membrane protein ectodomain proteolysis (GO:0006509) | 2.92906987 |
| 68 | mitotic sister chromatid cohesion (GO:0007064) | 2.92084716 |
| 69 | tRNA aminoacylation (GO:0043039) | 2.91293562 |
| 70 | amino acid activation (GO:0043038) | 2.91293562 |
| 71 | proline biosynthetic process (GO:0006561) | 2.89412423 |
| 72 | glutathione derivative metabolic process (GO:1901685) | 2.89219592 |
| 73 | glutathione derivative biosynthetic process (GO:1901687) | 2.89219592 |
| 74 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.86323252 |
| 75 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.85648896 |
| 76 | establishment of viral latency (GO:0019043) | 2.84564867 |
| 77 | regulation of translational fidelity (GO:0006450) | 2.84015964 |
| 78 | membrane disassembly (GO:0030397) | 2.83820675 |
| 79 | nuclear envelope disassembly (GO:0051081) | 2.83820675 |
| 80 | triglyceride biosynthetic process (GO:0019432) | 2.81309272 |
| 81 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.81183875 |
| 82 | serine transport (GO:0032329) | 2.80778480 |
| 83 | isoprenoid biosynthetic process (GO:0008299) | 2.80657883 |
| 84 | L-serine metabolic process (GO:0006563) | 2.79791585 |
| 85 | regulation of mitotic spindle organization (GO:0060236) | 2.79510886 |
| 86 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.79466269 |
| 87 | thioester metabolic process (GO:0035383) | 2.78892319 |
| 88 | acyl-CoA metabolic process (GO:0006637) | 2.78892319 |
| 89 | neutral lipid biosynthetic process (GO:0046460) | 2.77636385 |
| 90 | acylglycerol biosynthetic process (GO:0046463) | 2.77636385 |
| 91 | negative regulation of acute inflammatory response (GO:0002674) | 2.77151689 |
| 92 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.76771515 |
| 93 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.76771515 |
| 94 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.76771515 |
| 95 | mesodermal cell differentiation (GO:0048333) | 2.75098634 |
| 96 | glycerophospholipid catabolic process (GO:0046475) | 2.73713003 |
| 97 | mitochondrial DNA replication (GO:0006264) | 2.73337573 |
| 98 | positive regulation of chromosome segregation (GO:0051984) | 2.73149009 |
| 99 | protein localization to chromosome, centromeric region (GO:0071459) | 2.73055313 |
| 100 | response to phenylpropanoid (GO:0080184) | 2.72896153 |
| 101 | iron ion import (GO:0097286) | 2.72550486 |
| 102 | asymmetric protein localization (GO:0008105) | 2.70576445 |
| 103 | cholesterol metabolic process (GO:0008203) | 2.68668672 |
| 104 | oligodendrocyte differentiation (GO:0048709) | 2.67463900 |
| 105 | mitotic chromosome condensation (GO:0007076) | 2.67129324 |
| 106 | phosphatidylserine metabolic process (GO:0006658) | 2.66457933 |
| 107 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.65316361 |
| 108 | mitotic sister chromatid segregation (GO:0000070) | 2.64618817 |
| 109 | serine family amino acid biosynthetic process (GO:0009070) | 2.64080085 |
| 110 | formation of translation preinitiation complex (GO:0001731) | 2.63570245 |
| 111 | protein complex localization (GO:0031503) | 2.63191572 |
| 112 | ER overload response (GO:0006983) | 2.62950616 |
| 113 | mitotic cytokinesis (GO:0000281) | 2.62890203 |
| 114 | heme transport (GO:0015886) | 2.60588603 |
| 115 | response to X-ray (GO:0010165) | 2.60366855 |
| 116 | cellular protein complex localization (GO:0034629) | 2.60043555 |
| 117 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.59751687 |
| 118 | myeloid cell homeostasis (GO:0002262) | 2.59521004 |
| 119 | ethanol metabolic process (GO:0006067) | 2.59467594 |
| 120 | cellular copper ion homeostasis (GO:0006878) | 2.59401651 |
| 121 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.58671879 |
| 122 | protein maturation by protein folding (GO:0022417) | 2.58084677 |
| 123 | proteasome assembly (GO:0043248) | 2.57951646 |
| 124 | regulation of metalloenzyme activity (GO:0048552) | 2.57183041 |
| 125 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56486006 |
| 126 | paraxial mesoderm development (GO:0048339) | 2.55729730 |
| 127 | protein localization to kinetochore (GO:0034501) | 2.55637199 |
| 128 | wound healing, spreading of cells (GO:0044319) | 2.55628841 |
| 129 | cysteine metabolic process (GO:0006534) | 2.54816313 |
| 130 | sister chromatid segregation (GO:0000819) | 2.53814033 |
| 131 | positive regulation of macrophage activation (GO:0043032) | 2.53696176 |
| 132 | regulation of chromosome segregation (GO:0051983) | 2.53409691 |
| 133 | alpha-linolenic acid metabolic process (GO:0036109) | 2.52787522 |
| 134 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.52531604 |
| 135 | cullin deneddylation (GO:0010388) | 2.52506000 |
| 136 | membrane raft organization (GO:0031579) | 2.52463612 |
| 137 | mitochondrial DNA metabolic process (GO:0032042) | 2.52055646 |
| 138 | polarized epithelial cell differentiation (GO:0030859) | 2.51474072 |
| 139 | cellular modified amino acid biosynthetic process (GO:0042398) | 2.51458458 |
| 140 | signal peptide processing (GO:0006465) | 2.50628744 |
| 141 | NADP metabolic process (GO:0006739) | 2.50247940 |
| 142 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.50095171 |
| 143 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.49662176 |
| 144 | regulation of spindle organization (GO:0090224) | 2.49090722 |
| 145 | peptidyl-asparagine modification (GO:0018196) | 2.48965211 |
| 146 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.48642671 |
| 147 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.48209757 |
| 148 | sterol metabolic process (GO:0016125) | 2.47934661 |
| 149 | protein hydroxylation (GO:0018126) | 2.46545513 |
| 150 | membrane budding (GO:0006900) | 2.46051465 |
| 151 | cellular response to vitamin D (GO:0071305) | 2.45871539 |
| 152 | glomerular visceral epithelial cell development (GO:0072015) | 2.45629706 |
| 153 | desmosome organization (GO:0002934) | 2.45093028 |
| 154 | apical protein localization (GO:0045176) | 2.45004124 |
| 155 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.44661412 |
| 156 | primary alcohol catabolic process (GO:0034310) | 2.44624194 |
| 157 | short-chain fatty acid metabolic process (GO:0046459) | 2.44195559 |
| 158 | drug transmembrane transport (GO:0006855) | 2.43749841 |
| 159 | response to redox state (GO:0051775) | 2.41137467 |
| 160 | * sphingosine metabolic process (GO:0006670) | 2.40143591 |
| 161 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.39967752 |
| 162 | protein retention in ER lumen (GO:0006621) | 2.39332287 |
| 163 | L-amino acid import (GO:0043092) | 2.38459143 |
| 164 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.38119415 |
| 165 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.37948266 |
| 166 | DNA unwinding involved in DNA replication (GO:0006268) | 2.37005040 |
| 167 | positive regulation of osteoblast proliferation (GO:0033690) | 2.36994301 |
| 168 | mammary gland epithelial cell proliferation (GO:0033598) | 2.36578926 |
| 169 | regulation of neuron projection regeneration (GO:0070570) | 2.35400910 |
| 170 | regulation of axon regeneration (GO:0048679) | 2.35400910 |
| 171 | gap junction assembly (GO:0016264) | 2.35130881 |
| 172 | carbohydrate derivative transport (GO:1901264) | 2.34486717 |
| 173 | Leydig cell differentiation (GO:0033327) | 2.33366425 |
| 174 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.33083700 |
| 175 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.32730111 |
| 176 | positive regulation of glial cell differentiation (GO:0045687) | 2.32311056 |
| 177 | * sphingoid metabolic process (GO:0046519) | 2.30636305 |
| 178 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.30545331 |
| 179 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.30545331 |
| 180 | ethanol oxidation (GO:0006069) | 2.30297674 |
| 181 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30122973 |
| 182 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.30122973 |
| 183 | protein N-linked glycosylation (GO:0006487) | 2.29846628 |
| 184 | regulation of collateral sprouting (GO:0048670) | 2.29306764 |
| 185 | alditol phosphate metabolic process (GO:0052646) | 2.28485701 |
| 186 | negative regulation of DNA repair (GO:0045738) | 2.28356090 |
| 187 | neuron remodeling (GO:0016322) | 2.27769642 |
| 188 | neutrophil activation involved in immune response (GO:0002283) | 2.27373197 |
| 189 | epithelial cell-cell adhesion (GO:0090136) | 2.27260610 |
| 190 | GPI anchor biosynthetic process (GO:0006506) | 2.26871997 |
| 191 | positive regulation of interleukin-17 production (GO:0032740) | 2.26866576 |
| 192 | peptidyl-proline hydroxylation (GO:0019511) | 2.26589230 |
| 193 | DNA duplex unwinding (GO:0032508) | 2.26476923 |
| 194 | acetyl-CoA metabolic process (GO:0006084) | 2.26294580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.79264707 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.79180663 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.05412547 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.75154255 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.41752918 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.26959383 |
| 7 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.86212722 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84544113 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.66228948 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64969551 |
| 11 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.59960897 |
| 12 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.59298690 |
| 13 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.55122895 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.47237398 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37523412 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35364313 |
| 17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.33864606 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.31060236 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29431930 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.27937407 |
| 21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23914805 |
| 22 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.17786486 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.16214253 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12887922 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.11807045 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.10684617 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.10143898 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.05505122 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.04094953 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03234065 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00090258 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96935057 |
| 33 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.94442935 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92166343 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92030367 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.91784004 |
| 37 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.91652462 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.84082900 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83157773 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81015478 |
| 41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.79644454 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.78223966 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.78218909 |
| 44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77373385 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76310281 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74901032 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.73706998 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71179273 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67877161 |
| 50 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.63238144 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63148016 |
| 52 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.59895307 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.59348695 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59222099 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54109358 |
| 56 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53668219 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53579706 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52608759 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51664490 |
| 60 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50634408 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.50222941 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46980674 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.46693995 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45900717 |
| 65 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.45077601 |
| 66 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.40182469 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40042131 |
| 68 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36912230 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35058279 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34482036 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34318869 |
| 72 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.32273482 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30773952 |
| 74 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29921577 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26854949 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26695606 |
| 77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26342039 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25656295 |
| 79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25143859 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24533242 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23344591 |
| 82 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22308810 |
| 83 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21869882 |
| 84 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.21545775 |
| 85 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21277150 |
| 86 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.20670546 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18967454 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18440331 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18440331 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17222456 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17201469 |
| 92 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16861807 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16487433 |
| 94 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.15818647 |
| 95 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13549232 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13405264 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12644624 |
| 98 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12196842 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11654617 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11585532 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09676731 |
| 102 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.09290934 |
| 103 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08916382 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08316988 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07127092 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07093841 |
| 107 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06689887 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06472130 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04591680 |
| 110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03011387 |
| 111 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01940127 |
| 112 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01748558 |
| 113 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01509137 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01011767 |
| 115 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00971763 |
| 116 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00020893 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99952102 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99763272 |
| 119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.99758260 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99501714 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98616693 |
| 122 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98362905 |
| 123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.98356605 |
| 124 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97516133 |
| 125 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97142331 |
| 126 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95983409 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95857552 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95603014 |
| 129 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95395667 |
| 130 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94016449 |
| 131 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93378766 |
| 132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93378766 |
| 133 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92999862 |
| 134 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92609491 |
| 135 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92525552 |
| 136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92457514 |
| 137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91704491 |
| 138 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.91249047 |
| 139 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90466740 |
| 140 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89937369 |
| 141 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89102303 |
| 142 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.88521671 |
| 143 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88365070 |
| 144 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87208573 |
| 145 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.87169784 |
| 146 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86501268 |
| 147 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86280701 |
| 148 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86026949 |
| 149 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85877031 |
| 150 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85422153 |
| 151 | MYB_26560356_Chip-Seq_TH2_Human | 0.85398434 |
| 152 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85201517 |
| 153 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84138811 |
| 154 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83117225 |
| 155 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82858990 |
| 156 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82625813 |
| 157 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.81794233 |
| 158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81399757 |
| 159 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.80809415 |
| 160 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79857990 |
| 161 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79247946 |
| 162 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78853417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.31576966 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.00622437 |
| 3 | MP0000920_abnormal_myelination | 3.50327091 |
| 4 | MP0003941_abnormal_skin_development | 3.45799801 |
| 5 | MP0009840_abnormal_foam_cell | 3.27370262 |
| 6 | MP0005451_abnormal_body_composition | 3.13737288 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 3.06976675 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.04181648 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.97927194 |
| 10 | MP0002796_impaired_skin_barrier | 2.79740219 |
| 11 | MP0010678_abnormal_skin_adnexa | 2.77038820 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.72680428 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.66197643 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.51949395 |
| 15 | MP0005360_urolithiasis | 2.48290027 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.40124647 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.36162453 |
| 18 | MP0000383_abnormal_hair_follicle | 2.32597483 |
| 19 | MP0010094_abnormal_chromosome_stability | 2.30248945 |
| 20 | MP0003693_abnormal_embryo_hatching | 2.26956957 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.10607715 |
| 22 | MP0008057_abnormal_DNA_replication | 2.03508077 |
| 23 | MP0009697_abnormal_copulation | 2.01419818 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.99360897 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.93974570 |
| 26 | MP0003690_abnormal_glial_cell | 1.93530560 |
| 27 | MP0006054_spinal_hemorrhage | 1.88709319 |
| 28 | MP0009384_cardiac_valve_regurgitation | 1.86263417 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.83629721 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.79504445 |
| 31 | MP0004381_abnormal_hair_follicle | 1.78734386 |
| 32 | MP0003111_abnormal_nucleus_morphology | 1.77907156 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.77248568 |
| 34 | MP0005501_abnormal_skin_physiology | 1.75242784 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.73633461 |
| 36 | MP0000604_amyloidosis | 1.73551664 |
| 37 | MP0002060_abnormal_skin_morphology | 1.69098646 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.68501218 |
| 39 | MP0004947_skin_inflammation | 1.67643659 |
| 40 | MP0003077_abnormal_cell_cycle | 1.67373690 |
| 41 | MP0000647_abnormal_sebaceous_gland | 1.63130847 |
| 42 | MP0003329_amyloid_beta_deposits | 1.62219687 |
| 43 | MP0005408_hypopigmentation | 1.60939972 |
| 44 | MP0002098_abnormal_vibrissa_morphology | 1.51459276 |
| 45 | MP0000377_abnormal_hair_follicle | 1.50377585 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.47328934 |
| 47 | MP0008058_abnormal_DNA_repair | 1.47207751 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.45127689 |
| 49 | MP0001216_abnormal_epidermal_layer | 1.44484671 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.43414276 |
| 51 | MP0001730_embryonic_growth_arrest | 1.40116876 |
| 52 | MP0001915_intracranial_hemorrhage | 1.38943656 |
| 53 | MP0003136_yellow_coat_color | 1.38640648 |
| 54 | MP0001851_eye_inflammation | 1.37925150 |
| 55 | MP0005365_abnormal_bile_salt | 1.35881147 |
| 56 | MP0006082_CNS_inflammation | 1.35246389 |
| 57 | MP0004043_abnormal_pH_regulation | 1.35147427 |
| 58 | MP0005332_abnormal_amino_acid | 1.34386995 |
| 59 | MP0010771_integument_phenotype | 1.32758144 |
| 60 | MP0001958_emphysema | 1.31766489 |
| 61 | MP0003724_increased_susceptibility_to | 1.28716514 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.24798298 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.24633309 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.23713788 |
| 65 | MP0005275_abnormal_skin_tensile | 1.22468211 |
| 66 | MP0002086_abnormal_extraembryonic_tissu | 1.18274933 |
| 67 | MP0000467_abnormal_esophagus_morphology | 1.18126405 |
| 68 | MP0001672_abnormal_embryogenesis/_devel | 1.17443646 |
| 69 | MP0005380_embryogenesis_phenotype | 1.17443646 |
| 70 | MP0010307_abnormal_tumor_latency | 1.16549402 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.15833392 |
| 72 | MP0003195_calcinosis | 1.15547908 |
| 73 | MP0003718_maternal_effect | 1.14483334 |
| 74 | MP0001346_abnormal_lacrimal_gland | 1.13265777 |
| 75 | MP0004233_abnormal_muscle_weight | 1.13180809 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.11563115 |
| 77 | MP0004885_abnormal_endolymph | 1.11471144 |
| 78 | MP0003091_abnormal_cell_migration | 1.11339854 |
| 79 | MP0000350_abnormal_cell_proliferation | 1.10904068 |
| 80 | MP0003984_embryonic_growth_retardation | 1.10811348 |
| 81 | MP0000685_abnormal_immune_system | 1.10758013 |
| 82 | MP0005621_abnormal_cell_physiology | 1.10404376 |
| 83 | MP0004272_abnormal_basement_membrane | 1.07127715 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 1.07078888 |
| 85 | MP0001243_abnormal_dermal_layer | 1.06876148 |
| 86 | MP0001697_abnormal_embryo_size | 1.06831058 |
| 87 | MP0001661_extended_life_span | 1.05386170 |
| 88 | * MP0002118_abnormal_lipid_homeostasis | 1.05112698 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04990201 |
| 90 | MP0002084_abnormal_developmental_patter | 1.04933474 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 1.04127974 |
| 92 | MP0001299_abnormal_eye_distance/ | 1.03170042 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 1.03046045 |
| 94 | MP0003634_abnormal_glial_cell | 1.02988076 |
| 95 | MP0000358_abnormal_cell_content/ | 1.01817439 |
| 96 | MP0003186_abnormal_redox_activity | 1.01540649 |
| 97 | * MP0002080_prenatal_lethality | 1.01251519 |
| 98 | MP0003786_premature_aging | 0.98469230 |
| 99 | MP0005384_cellular_phenotype | 0.97695293 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.95675404 |
| 101 | MP0002006_tumorigenesis | 0.95115415 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.95065330 |
| 103 | MP0000579_abnormal_nail_morphology | 0.94755894 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.94190785 |
| 105 | MP0000627_abnormal_mammary_gland | 0.93585026 |
| 106 | MP0004147_increased_porphyrin_level | 0.93229607 |
| 107 | MP0008260_abnormal_autophagy | 0.91519749 |
| 108 | MP0001191_abnormal_skin_condition | 0.91290225 |
| 109 | MP0000462_abnormal_digestive_system | 0.91118507 |
| 110 | MP0002933_joint_inflammation | 0.90065178 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.89414967 |
| 112 | MP0000609_abnormal_liver_physiology | 0.88917600 |
| 113 | MP0004197_abnormal_fetal_growth/weight/ | 0.86765505 |
| 114 | MP0002009_preneoplasia | 0.85818319 |
| 115 | MP0003448_altered_tumor_morphology | 0.85461817 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.84811658 |
| 117 | MP0002419_abnormal_innate_immunity | 0.84679063 |
| 118 | MP0002254_reproductive_system_inflammat | 0.83239760 |
| 119 | MP0005025_abnormal_response_to | 0.83148355 |
| 120 | MP0002085_abnormal_embryonic_tissue | 0.82847236 |
| 121 | MP0005000_abnormal_immune_tolerance | 0.82441323 |
| 122 | MP0003385_abnormal_body_wall | 0.81502079 |
| 123 | MP0010329_abnormal_lipoprotein_level | 0.80890069 |
| 124 | MP0009931_abnormal_skin_appearance | 0.80749963 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.79770797 |
| 126 | MP0001533_abnormal_skeleton_physiology | 0.77509232 |
| 127 | MP0003632_abnormal_nervous_system | 0.76446937 |
| 128 | MP0001849_ear_inflammation | 0.75828620 |
| 129 | MP0000858_altered_metastatic_potential | 0.74733277 |
| 130 | MP0001873_stomach_inflammation | 0.73630090 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.73382630 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.72750055 |
| 133 | MP0000427_abnormal_hair_cycle | 0.72566289 |
| 134 | MP0009703_decreased_birth_body | 0.71860801 |
| 135 | MP0003436_decreased_susceptibility_to | 0.71541723 |
| 136 | MP0004019_abnormal_vitamin_homeostasis | 0.70954494 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.70241291 |
| 138 | MP0000537_abnormal_urethra_morphology | 0.69841975 |
| 139 | MP0005387_immune_system_phenotype | 0.69359143 |
| 140 | MP0001790_abnormal_immune_system | 0.69359143 |
| 141 | MP0005083_abnormal_biliary_tract | 0.68900879 |
| 142 | MP0005503_abnormal_tendon_morphology | 0.68463262 |
| 143 | MP0009763_increased_sensitivity_to | 0.67539742 |
| 144 | MP0002723_abnormal_immune_serum | 0.66921304 |
| 145 | MP0000762_abnormal_tongue_morphology | 0.66228728 |
| 146 | MP0005023_abnormal_wound_healing | 0.65555091 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.65496890 |
| 148 | MP0009672_abnormal_birth_weight | 0.65447240 |
| 149 | MP0002092_abnormal_eye_morphology | 0.65293807 |
| 150 | MP0002697_abnormal_eye_size | 0.64643850 |
| 151 | MP0005508_abnormal_skeleton_morphology | 0.64111219 |
| 152 | MP0000767_abnormal_smooth_muscle | 0.63524037 |
| 153 | MP0008469_abnormal_protein_level | 0.62977522 |
| 154 | MP0005310_abnormal_salivary_gland | 0.62300042 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62240240 |
| 156 | MP0005395_other_phenotype | 0.61952453 |
| 157 | MP0000747_muscle_weakness | 0.61840910 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.61786794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 5.96409010 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.68319008 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.13348969 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.13348969 |
| 5 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.83970633 |
| 6 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.75621750 |
| 7 | Atrophic scars (HP:0001075) | 3.65670796 |
| 8 | Onycholysis (HP:0001806) | 3.46487699 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.40379861 |
| 10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.39568991 |
| 11 | Alopecia of scalp (HP:0002293) | 3.38582602 |
| 12 | Spastic paraparesis (HP:0002313) | 3.23434886 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.23059652 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.14701916 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.12134370 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.10570843 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.10309733 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.09839314 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04534385 |
| 20 | Sensory axonal neuropathy (HP:0003390) | 3.00441882 |
| 21 | Selective tooth agenesis (HP:0001592) | 2.98146989 |
| 22 | Arterial tortuosity (HP:0005116) | 2.97827020 |
| 23 | Vascular tortuosity (HP:0004948) | 2.96132294 |
| 24 | Plantar hyperkeratosis (HP:0007556) | 2.93417525 |
| 25 | Erythroderma (HP:0001019) | 2.91642450 |
| 26 | Follicular hyperkeratosis (HP:0007502) | 2.90699360 |
| 27 | Increased serum pyruvate (HP:0003542) | 2.84519922 |
| 28 | Abnormality of glycolysis (HP:0004366) | 2.84519922 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 2.83784657 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.82101546 |
| 31 | Premature skin wrinkling (HP:0100678) | 2.80224217 |
| 32 | Stridor (HP:0010307) | 2.79557023 |
| 33 | Abnormality of oral frenula (HP:0000190) | 2.76309790 |
| 34 | Hepatosplenomegaly (HP:0001433) | 2.75766042 |
| 35 | Entropion (HP:0000621) | 2.72088723 |
| 36 | Ankyloglossia (HP:0010296) | 2.70468261 |
| 37 | Termporal pattern (HP:0011008) | 2.70137971 |
| 38 | Insidious onset (HP:0003587) | 2.70137971 |
| 39 | Fragile skin (HP:0001030) | 2.67285404 |
| 40 | Palmar hyperkeratosis (HP:0010765) | 2.63238495 |
| 41 | Abnormality of nail color (HP:0100643) | 2.63108401 |
| 42 | Palmoplantar hyperkeratosis (HP:0000972) | 2.61390113 |
| 43 | Papillary thyroid carcinoma (HP:0002895) | 2.59923431 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.55013018 |
| 45 | Deep venous thrombosis (HP:0002625) | 2.54463102 |
| 46 | Hypokalemic alkalosis (HP:0001949) | 2.53759767 |
| 47 | Xanthomatosis (HP:0000991) | 2.53321054 |
| 48 | Loss of speech (HP:0002371) | 2.53252594 |
| 49 | Ankle contracture (HP:0006466) | 2.52023335 |
| 50 | Hypoplastic pelvis (HP:0008839) | 2.47208991 |
| 51 | Aortic dissection (HP:0002647) | 2.45011212 |
| 52 | Chronic otitis media (HP:0000389) | 2.42887678 |
| 53 | Cortical dysplasia (HP:0002539) | 2.41553772 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.41204287 |
| 55 | Microglossia (HP:0000171) | 2.34180241 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.32344417 |
| 57 | Pustule (HP:0200039) | 2.29069528 |
| 58 | Wormian bones (HP:0002645) | 2.27660468 |
| 59 | Sparse eyelashes (HP:0000653) | 2.26734114 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.24625798 |
| 61 | Cervical subluxation (HP:0003308) | 2.24490955 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.24405178 |
| 63 | Abnormality of glycine metabolism (HP:0010895) | 2.24405178 |
| 64 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.24184097 |
| 65 | Pili torti (HP:0003777) | 2.23305970 |
| 66 | Soft skin (HP:0000977) | 2.21326920 |
| 67 | Bladder diverticulum (HP:0000015) | 2.20669384 |
| 68 | Natal tooth (HP:0000695) | 2.20428527 |
| 69 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.19002537 |
| 70 | Metabolic alkalosis (HP:0200114) | 2.13825582 |
| 71 | Chromsome breakage (HP:0040012) | 2.13237141 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.12599055 |
| 73 | Orthostatic hypotension (HP:0001278) | 2.12466490 |
| 74 | Blepharitis (HP:0000498) | 2.12026325 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10868500 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.10868500 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.10452562 |
| 78 | Fragile nails (HP:0001808) | 2.09852487 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.09082629 |
| 80 | Tetraparesis (HP:0002273) | 2.08264016 |
| 81 | Thyroid carcinoma (HP:0002890) | 2.07963518 |
| 82 | Peripheral hypomyelination (HP:0007182) | 2.07265113 |
| 83 | Seborrheic dermatitis (HP:0001051) | 2.05976404 |
| 84 | Abnormality of placental membranes (HP:0011409) | 2.03833682 |
| 85 | Amniotic constriction ring (HP:0009775) | 2.03833682 |
| 86 | Steatorrhea (HP:0002570) | 2.03767189 |
| 87 | Fat malabsorption (HP:0002630) | 2.02690454 |
| 88 | Decreased skull ossification (HP:0004331) | 2.01486490 |
| 89 | Abnormality of the umbilical cord (HP:0010881) | 2.01309125 |
| 90 | Septate vagina (HP:0001153) | 2.00448055 |
| 91 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.00390485 |
| 92 | Clitoromegaly (HP:0000057) | 2.00278707 |
| 93 | Hypoplasia of the iris (HP:0007676) | 1.98435757 |
| 94 | Spastic diplegia (HP:0001264) | 1.97941778 |
| 95 | Pterygium (HP:0001059) | 1.97558694 |
| 96 | Nail dystrophy (HP:0008404) | 1.94995163 |
| 97 | Cerebral hypomyelination (HP:0006808) | 1.94769709 |
| 98 | Milia (HP:0001056) | 1.94519475 |
| 99 | Periodontitis (HP:0000704) | 1.94499407 |
| 100 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93874424 |
| 101 | Deviation of the thumb (HP:0009603) | 1.93874030 |
| 102 | Abnormal auditory evoked potentials (HP:0006958) | 1.93847637 |
| 103 | Purpura (HP:0000979) | 1.92861577 |
| 104 | Deep philtrum (HP:0002002) | 1.92640770 |
| 105 | Asymmetry of the thorax (HP:0001555) | 1.91315081 |
| 106 | Curly hair (HP:0002212) | 1.91313236 |
| 107 | Paraparesis (HP:0002385) | 1.90989460 |
| 108 | Esophageal atresia (HP:0002032) | 1.89441798 |
| 109 | Increased circulating renin level (HP:0000848) | 1.88764504 |
| 110 | Amyloidosis (HP:0011034) | 1.88550195 |
| 111 | Thick nail (HP:0001805) | 1.88308998 |
| 112 | Breech presentation (HP:0001623) | 1.87908364 |
| 113 | Protuberant abdomen (HP:0001538) | 1.87143692 |
| 114 | Hand muscle atrophy (HP:0009130) | 1.86733559 |
| 115 | Increased nuchal translucency (HP:0010880) | 1.85936176 |
| 116 | Abnormal delivery (HP:0001787) | 1.85819235 |
| 117 | Insomnia (HP:0100785) | 1.85509291 |
| 118 | Coronal craniosynostosis (HP:0004440) | 1.84876854 |
| 119 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.83596937 |
| 120 | Clumsiness (HP:0002312) | 1.83046027 |
| 121 | Malnutrition (HP:0004395) | 1.82412463 |
| 122 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82372729 |
| 123 | Absent eyelashes (HP:0000561) | 1.81358095 |
| 124 | Abnormal hair laboratory examination (HP:0003328) | 1.80796226 |
| 125 | Cerebral hemorrhage (HP:0001342) | 1.79572237 |
| 126 | Upper limb muscle weakness (HP:0003484) | 1.79082503 |
| 127 | Hypokinesia (HP:0002375) | 1.78869838 |
| 128 | Ectropion (HP:0000656) | 1.78678651 |
| 129 | Hematochezia (HP:0002573) | 1.76528280 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.74345205 |
| 131 | Subacute progressive viral hepatitis (HP:0006572) | 1.74312360 |
| 132 | Thin skin (HP:0000963) | 1.73993146 |
| 133 | Nonimmune hydrops fetalis (HP:0001790) | 1.73898561 |
| 134 | Erythema (HP:0010783) | 1.72757393 |
| 135 | Onion bulb formation (HP:0003383) | 1.72644396 |
| 136 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72360193 |
| 137 | Stenosis of the external auditory canal (HP:0000402) | 1.72168984 |
| 138 | Hypomagnesemia (HP:0002917) | 1.72080719 |
| 139 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.71868914 |
| 140 | Single umbilical artery (HP:0001195) | 1.71868914 |
| 141 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.71868914 |
| 142 | Anteriorly placed anus (HP:0001545) | 1.71470355 |
| 143 | Humeroradial synostosis (HP:0003041) | 1.71380605 |
| 144 | Synostosis involving the elbow (HP:0003938) | 1.71380605 |
| 145 | Interstitial pulmonary disease (HP:0006530) | 1.71304589 |
| 146 | Ependymoma (HP:0002888) | 1.71072046 |
| 147 | Relative macrocephaly (HP:0004482) | 1.71040646 |
| 148 | Abnormality of the acetabulum (HP:0003170) | 1.69936976 |
| 149 | Cholecystitis (HP:0001082) | 1.69903102 |
| 150 | Abnormal gallbladder physiology (HP:0012438) | 1.69903102 |
| 151 | Abnormal tarsal ossification (HP:0008369) | 1.69760897 |
| 152 | Abnormality of skull ossification (HP:0002703) | 1.69750587 |
| 153 | Ulnar bowing (HP:0003031) | 1.69577190 |
| 154 | Secondary amenorrhea (HP:0000869) | 1.69565671 |
| 155 | Increased serum ferritin (HP:0003281) | 1.69328255 |
| 156 | Patchy hypopigmentation of hair (HP:0011365) | 1.68797298 |
| 157 | Dilatation of the ascending aorta (HP:0005111) | 1.68090831 |
| 158 | Cutaneous melanoma (HP:0012056) | 1.68084066 |
| 159 | Hyperglycinuria (HP:0003108) | 1.67869705 |
| 160 | Short middle phalanx of the 5th finger (HP:0004220) | 1.66902249 |
| 161 | Spinal rigidity (HP:0003306) | 1.66590198 |
| 162 | Freckling (HP:0001480) | 1.66495073 |
| 163 | Supranuclear gaze palsy (HP:0000605) | 1.66161681 |
| 164 | Microvesicular hepatic steatosis (HP:0001414) | 1.66097664 |
| 165 | Postnatal microcephaly (HP:0005484) | 1.66084397 |
| 166 | Abnormality of methionine metabolism (HP:0010901) | 1.65364011 |
| 167 | Axonal loss (HP:0003447) | 1.65047852 |
| 168 | Adrenal hypoplasia (HP:0000835) | 1.64509697 |
| 169 | Abnormality of the lumbar spine (HP:0100712) | 1.64479726 |
| 170 | Advanced eruption of teeth (HP:0006288) | 1.64249043 |
| 171 | Proximal placement of thumb (HP:0009623) | 1.62890759 |
| 172 | Delayed cranial suture closure (HP:0000270) | 1.62850607 |
| 173 | Mitral stenosis (HP:0001718) | 1.62411687 |
| 174 | Hoarse voice (HP:0001609) | 1.62388802 |
| 175 | Peritonitis (HP:0002586) | 1.61816952 |
| 176 | Corneal erosion (HP:0200020) | 1.61008132 |
| 177 | Abnormal foot bone ossification (HP:0010675) | 1.60992064 |
| 178 | Lack of skin elasticity (HP:0100679) | 1.60946638 |
| 179 | Persistence of primary teeth (HP:0006335) | 1.60330062 |
| 180 | Squamous cell carcinoma (HP:0002860) | 1.60056973 |
| 181 | Conjunctival telangiectasia (HP:0000524) | 1.59058846 |
| 182 | Partial duplication of thumb phalanx (HP:0009944) | 1.58405800 |
| 183 | Macrocytic anemia (HP:0001972) | 1.58259474 |
| 184 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.56444346 |
| 185 | Palpitations (HP:0001962) | 1.56434432 |
| 186 | Abnormality of dentin (HP:0010299) | 1.56295473 |
| 187 | Cardiovascular calcification (HP:0011915) | 1.55276378 |
| 188 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.54206067 |
| 189 | Skull defect (HP:0001362) | 1.53913626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.54896623 |
| 2 | OXSR1 | 3.83229636 |
| 3 | EPHB1 | 3.59814725 |
| 4 | MST4 | 3.41643590 |
| 5 | TSSK6 | 3.02591024 |
| 6 | EIF2AK1 | 2.74681119 |
| 7 | TRPM7 | 2.72656621 |
| 8 | MAPKAPK5 | 2.67985425 |
| 9 | STK10 | 2.65460975 |
| 10 | TTK | 2.61189239 |
| 11 | MET | 2.59346784 |
| 12 | NEK1 | 2.32036126 |
| 13 | MAP3K12 | 2.19787695 |
| 14 | SRPK1 | 2.06136349 |
| 15 | PAK4 | 1.97133210 |
| 16 | KDR | 1.87290126 |
| 17 | WNK4 | 1.77913917 |
| 18 | CDK19 | 1.76623077 |
| 19 | STK38L | 1.74399833 |
| 20 | LRRK2 | 1.73576521 |
| 21 | PDGFRA | 1.73425061 |
| 22 | MAPKAPK3 | 1.73085714 |
| 23 | MAP3K13 | 1.71566374 |
| 24 | ITK | 1.69430756 |
| 25 | PBK | 1.67428182 |
| 26 | TESK2 | 1.67030379 |
| 27 | PDK2 | 1.66880053 |
| 28 | ERBB3 | 1.64419081 |
| 29 | ERBB4 | 1.61983701 |
| 30 | EEF2K | 1.61854215 |
| 31 | BRSK2 | 1.61176897 |
| 32 | MAP4K1 | 1.57323462 |
| 33 | TRIM28 | 1.52125386 |
| 34 | LATS2 | 1.47581485 |
| 35 | BCR | 1.47546842 |
| 36 | MOS | 1.46515993 |
| 37 | CSNK1A1L | 1.45432295 |
| 38 | FGFR2 | 1.44419841 |
| 39 | MAP2K2 | 1.40785287 |
| 40 | CSNK1G3 | 1.38546001 |
| 41 | CSNK1G1 | 1.37182879 |
| 42 | RPS6KA4 | 1.35316149 |
| 43 | PLK3 | 1.34493844 |
| 44 | BCKDK | 1.32539473 |
| 45 | RPS6KB2 | 1.29703002 |
| 46 | EPHA2 | 1.25234843 |
| 47 | LATS1 | 1.22325221 |
| 48 | PKN1 | 1.21369244 |
| 49 | KIT | 1.20224681 |
| 50 | FGFR4 | 1.20049021 |
| 51 | MAP3K3 | 1.17129898 |
| 52 | NEK6 | 1.16866715 |
| 53 | NEK9 | 1.13706870 |
| 54 | BRD4 | 1.13356419 |
| 55 | KSR1 | 1.11813925 |
| 56 | PTK2 | 1.10665497 |
| 57 | BUB1 | 1.10399039 |
| 58 | MKNK1 | 1.09849345 |
| 59 | LIMK1 | 1.09745516 |
| 60 | CDK6 | 1.09356557 |
| 61 | CSNK1G2 | 1.07769222 |
| 62 | MYLK | 1.07579224 |
| 63 | MST1R | 1.05076882 |
| 64 | ROCK2 | 1.04944495 |
| 65 | NTRK1 | 1.03934410 |
| 66 | FGR | 1.03670897 |
| 67 | MAP3K8 | 0.98240492 |
| 68 | CDK12 | 0.98158839 |
| 69 | BMPR2 | 0.96883310 |
| 70 | PDGFRB | 0.93439092 |
| 71 | CSK | 0.92809443 |
| 72 | MELK | 0.92713895 |
| 73 | KSR2 | 0.92636951 |
| 74 | EIF2AK3 | 0.85326426 |
| 75 | NLK | 0.85260905 |
| 76 | ERN1 | 0.84947897 |
| 77 | LMTK2 | 0.84790131 |
| 78 | PLK4 | 0.84227618 |
| 79 | PLK2 | 0.84151774 |
| 80 | EPHA3 | 0.84097204 |
| 81 | IRAK4 | 0.81320692 |
| 82 | TAOK3 | 0.81116274 |
| 83 | BRSK1 | 0.80814363 |
| 84 | BLK | 0.80437867 |
| 85 | STK24 | 0.77876961 |
| 86 | AKT3 | 0.77547614 |
| 87 | FGFR1 | 0.77190573 |
| 88 | AURKB | 0.77123382 |
| 89 | MAP3K11 | 0.76003877 |
| 90 | PRKD1 | 0.75421596 |
| 91 | PLK1 | 0.75010116 |
| 92 | MKNK2 | 0.74760415 |
| 93 | TGFBR2 | 0.73802028 |
| 94 | GSK3A | 0.73195505 |
| 95 | ARAF | 0.73152138 |
| 96 | TIE1 | 0.72183530 |
| 97 | PRKCQ | 0.71374560 |
| 98 | STK3 | 0.69811541 |
| 99 | ALK | 0.69402058 |
| 100 | LCK | 0.68477299 |
| 101 | RAF1 | 0.68286733 |
| 102 | CSF1R | 0.68198093 |
| 103 | RIPK1 | 0.67809642 |
| 104 | TYRO3 | 0.66928479 |
| 105 | JAK3 | 0.66851748 |
| 106 | MAPK15 | 0.66193035 |
| 107 | PAK3 | 0.65957713 |
| 108 | STK4 | 0.65820335 |
| 109 | SCYL2 | 0.62951345 |
| 110 | EIF2AK2 | 0.62761626 |
| 111 | BTK | 0.61520960 |
| 112 | SIK3 | 0.61115939 |
| 113 | MUSK | 0.60766423 |
| 114 | ZAP70 | 0.60631588 |
| 115 | TYK2 | 0.60609273 |
| 116 | ATM | 0.58540732 |
| 117 | CHEK1 | 0.58540081 |
| 118 | CLK1 | 0.58021467 |
| 119 | FER | 0.57870606 |
| 120 | ACVR1B | 0.55850015 |
| 121 | CDK9 | 0.54823426 |
| 122 | WNK1 | 0.54437873 |
| 123 | PAK2 | 0.54195442 |
| 124 | PTK6 | 0.52661075 |
| 125 | PIM2 | 0.52210854 |
| 126 | CAMK2B | 0.51709626 |
| 127 | GRK6 | 0.50951659 |
| 128 | CDK7 | 0.50590913 |
| 129 | RPS6KA5 | 0.50030123 |
| 130 | TEC | 0.49937241 |
| 131 | MAP3K14 | 0.49854784 |
| 132 | STK16 | 0.49804206 |
| 133 | CDC7 | 0.49549050 |
| 134 | PDPK1 | 0.48146000 |
| 135 | FYN | 0.47367680 |
| 136 | CAMK2G | 0.46960376 |
| 137 | YES1 | 0.45214115 |
| 138 | WEE1 | 0.44607971 |
| 139 | ICK | 0.44498586 |
| 140 | EGFR | 0.44484661 |
| 141 | PAK1 | 0.44031413 |
| 142 | BMX | 0.41947919 |
| 143 | TGFBR1 | 0.41812734 |
| 144 | MAP3K1 | 0.40940222 |
| 145 | IKBKB | 0.40310672 |
| 146 | CDK8 | 0.39904765 |
| 147 | JAK1 | 0.39466521 |
| 148 | MAP3K9 | 0.39268637 |
| 149 | TAF1 | 0.39193586 |
| 150 | TBK1 | 0.39035644 |
| 151 | CAMK2D | 0.38437677 |
| 152 | NEK2 | 0.36828932 |
| 153 | PRKCI | 0.36635288 |
| 154 | * ABL1 | 0.36493439 |
| 155 | ABL2 | 0.36446899 |
| 156 | IGF1R | 0.36364305 |
| 157 | MAPKAPK2 | 0.36275136 |
| 158 | HCK | 0.36246021 |
| 159 | INSR | 0.36156069 |
| 160 | MAP3K2 | 0.35553492 |
| 161 | PAK6 | 0.35395993 |
| 162 | BMPR1B | 0.35060441 |
| 163 | AKT2 | 0.35046624 |
| 164 | DYRK3 | 0.34973439 |
| 165 | PRKG2 | 0.31704625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.08586466 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.85646827 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.57134929 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.42873942 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.77170807 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.75243394 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.63971610 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.50395671 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.37850593 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.29719359 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.23121705 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20198186 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.16845312 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.15647968 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12951694 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.08825266 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 2.03796784 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99815858 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.97539041 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.80587683 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76705580 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.72869358 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.67291737 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.65441639 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63858113 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.62088789 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.60430759 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.60417858 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.60243628 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59066924 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.58338342 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.58329836 |
| 33 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.58106141 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.56860293 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56507342 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.53970266 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52370771 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47968249 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.47364605 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46722195 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 1.45874799 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.43698792 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42396896 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41967567 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.37245057 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35315673 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.33845885 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32073854 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26539801 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23488130 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19904596 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17456925 |
| 53 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.15458766 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.15065707 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 1.14927075 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10667908 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10323753 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07650189 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05465337 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04299592 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 1.04027642 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 1.03961919 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03164376 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.00380036 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00295790 |
| 66 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.94121863 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.93003229 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92269702 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91307308 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90890589 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90631644 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.89567187 |
| 73 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88281517 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87946674 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87051627 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.86801431 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83399317 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82989168 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.82787146 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81523018 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81156233 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78045105 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76950330 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.76909684 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.76198907 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75952019 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74969605 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.74867833 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72991731 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72699683 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.72233196 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69834337 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68167866 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.67713191 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.66613563 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66531232 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66206803 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.65836550 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64636253 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64209944 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63839547 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63644849 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63216717 |
| 104 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.63036973 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62558189 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62392878 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61761453 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60984091 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60829282 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.60600059 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59496768 |
| 112 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56771144 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55606470 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.54793521 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54779883 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54527585 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53870298 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53853830 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53839200 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53316588 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53293861 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.52765570 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50867702 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50018703 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.49981719 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46928593 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46257230 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.46036979 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.45997622 |
| 130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45451718 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.44864715 |
| 132 | Purine metabolism_Homo sapiens_hsa00230 | 0.43799057 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.43001991 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40482641 |
| 135 | Tight junction_Homo sapiens_hsa04530 | 0.39264464 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39226405 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37226867 |
| 138 | Melanoma_Homo sapiens_hsa05218 | 0.37034320 |
| 139 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35540536 |
| 140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35254414 |
| 141 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34697033 |
| 142 | Shigellosis_Homo sapiens_hsa05131 | 0.34378921 |
| 143 | Hepatitis B_Homo sapiens_hsa05161 | 0.34183623 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33057165 |
| 145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32761034 |
| 146 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32065198 |
| 147 | Basal transcription factors_Homo sapiens_hsa03022 | 0.29267639 |
| 148 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28995466 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28199815 |
| 150 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27993238 |
| 151 | Hepatitis C_Homo sapiens_hsa05160 | 0.26774932 |
| 152 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25427305 |
| 153 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24788058 |
| 154 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.24618103 |
| 155 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24270987 |
| 156 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24240803 |

